by TractManager | Dec 16, 2022 | Emerging Technology Report
TissueGene-C is an allogeneic cell and gene therapy delivered via intra-articular injection in development for the treatment of knee osteoarthritis.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Dec 12, 2022 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of PuraPly AM for wound healing in adult patients.If you have a Hayes login, click here to view the full report on...
by TractManager | Dec 9, 2022 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the direct application of the ReCell Autologous Cell Harvesting Device for the treatment of acute partial-thickness thermal...
by TractManager | Dec 9, 2022 | Molecular Test Assessment
This report evaluates the analytical validity, clinical validity, and clinical utility of the Prostate Health Index (phi) (Beckman Coulter Inc.).If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Dec 8, 2022 | Emerging Technology Report
Omburtamab is a radiolabeled monoclonal antibody targeting tumor antigen B7-H3 in development for intraventricular radioimmunotherapy for treatment of neuroblastoma central nervous system/leptomeningeal metastases.If you have a Hayes login, click here to view the full...
Recent Comments